Navigation Links
Pfizer Animal Health and NTRA Charities Team Up to Benefit the Barbaro Memorial Fund
Date:1/31/2008

Promotions Support Fund's Goal of Finding a Cure for Laminitis

NEW YORK, Jan. 31 /PRNewswire/ -- Pfizer Animal Health and the National Thoroughbred Racing Association (NTRA) have joined forces to help fund laminitis research through the NTRA Charities - Barbaro Memorial Fund. The partnership's aim is to increase awareness of the Fund across the horse industry and encourage further support of cutting edge research into laminitis prevention and treatment.

Owners, trainers and horse enthusiasts alike can contribute directly to the work of the Barbaro Memorial Fund online at RidingwithBarbaro.org. Information on the donation site, and the Fund's goal, will be featured in 2008 Pfizer Animal Health advertising for several equine products, as well as on displays in select retail outlets across the country and at major equine events. Riding with Barbaro awareness bracelets will be available as part of select display promotions.

"Laminitis is a potentially devastating disease that affects horses at all levels of equine sports and across disciplines -- from great Thoroughbred champions like Barbaro, right on to recreational horses loved by their riders and owners," said Kristin Ruff, marketing manager, U.S. equine business, at Pfizer Animal Health. "We wanted to help raise awareness of the Fund's mission and encourage all kinds of horse people to donate what they can toward finding a cure."

"Pfizer's generous contribution and commitment to promote the NTRA Charities - Barbaro Memorial Fund will help further his legacy, both as a courageous and gifted racehorse and as the inspiration for promising new research on equine health," said Alex Waldrop, president and CEO of the NTRA.

The entire horse industry, and horse enthusiasts around the world, watched Barbaro's story unfold after his tragic injury during the 2006 Preakness Stakes. Despite the heroic efforts of a team of leading veterinarians at the University of Pennsylvania's New B
'/>"/>

SOURCE Pfizer Animal Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
2. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
3. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
4. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
5. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
6. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
7. Study Shows Coronado Biosciences Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
8. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
9. Animal Protection Groups Condemn FDAs Endorsement of Animal Cloning
10. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
11. Smithfield Foods, Inc. Statement Regarding Animal Cloning
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3